Lymph node mapping with carbon nanoparticles and the risk factors of lymph node metastasis in gastric cancer

Abstract

The study aimed to examine the applicability of carbon nanoparticles as a tracer for lymph node mapping and the related factors of lymph node and No.8p subgroup metastasis in patients with gastric cancer. Clinical data of 50 patients with gastric cancer, who had not received treatment preoperatively and underwent gastrectomy in Department of Gastrointestinal Surgery, Wuhan Union Hospital, between October 2014 and August 2015, were retrospectively analyzed. These patients were found to have no distant metastasis preoperatively. Thirty-five out of 50 patients were subjected to lymphatic mapping technique using carbon nanoparticles as the tracer, and the rest 15 cases did not experience the lymphatic mapping and served as controls. The sensitivity, specificity, false positive rate and false negative rate were calculated according to the number of lymph nodes, and the staining and metastasis condition of lymph nodes. The diagnostic value of carbon nanoparticles on metastatic lymph nodes was evaluated. The relationship between the metastasis of lymph nodes or subgroup No.8p lymph nodes and clinicopathologic features was analyzed by χ²-test or Fisher’s exact test. All patients underwent D2 surgery (lymph node dissection including all the group 1 and group 2 nodes) plus the dissection of the subgroup No.8p lymph nodes. It was found that the average number of harvested lymph nodes in lymphatic mapping technique group (45.7±14.5) was greater than that in control group (39.2±11.7), but the difference was not significantly different (P=0.138>0.05). The success rate, the accuracy, sensitivity, specificity and false negative rate was 97%, 57%, 28%, 62% and 72% respectively. The metastasis of lymph nodes was correlated to the depth of cancer invasion (T stage) (P=0.004<0.05), and the metastasis of No.8p lymph nodes was correlated to the extent of lymph node involvement (N stage) (P=0.007<0.05). Six cases had lymph node metastasis in subgroup No.8p, and their TNM stages and clinical stages were as follows: T1N2M0 IIA, T3N3M0 IIIB, T4aN3M0 IIIC, T4aN3M0 IIIC, T4aN3M0 IIIC, and T4bN3M0 IIIC. In conclusion, our study indicated that carbon nanoparticles failed to show good selectivity for metastatic lymph nodes; the result of lymphatic mapping does not achieve a satisfactory performance; the incidence of lymph node metastasis may increase, accompanying with the increase of the depth of cancer invasion; No.8p lymph node metastasis tends to occur for gastric carcinoma patients with the extent of lymph node metastasis over N2 stage.

Keywords

stomach neoplasms / lymph node metastasis / carbon nanoparticles / lymph node mapping / No.8p lymph nodes

References

[1] JemalA, BrayF, CenterMM, et al. . Global cancer statistics. Cancer J Clin, 2011, 61(2): 69-90

[2] DickenBJ, BigamDL, CassC, et al. . Gastric Adenocarcinoma: Review and Considerations for Future Directions. Ann Surg, 2005, 241(1): 27-39 PMID: 15621988 PMCID: 1356843

[3] TanizawaY, TerashimaM. Lymph node dissection in the resection of gastric cancer: review of existing evidence. Gastric Cancer, 2010, 13(3): 137-148 PMID: 20820982

[4] SiewertJR, BöttcherK, SteinHJ, et al. . Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study. Ann Surg Oncol, 1998, 228(4): 449-461

[5] MarubiniE, BozzettiF, MiceliR, et al. . Lymphadenectomy in gastric cancer: prognostic role and therapeutic implications. EJSO, 2002, 28(4): 406-412 PMID: 12099651

[6] NoguchiY, ImadaT, MatsumotoA, et al. . Radical surgery for gastric cancer. A review of the Japanese experience. Cancer, 1989, 64(10): 2053-2062 PMID: 2680049

[7] RovielloF, RossiS, MarrelliD, et al. . Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol, 2006, 94(4): 275-280 PMID: 16917863

[8] AbeN, WatanabeT, SuzukiK, et al. . Risk factors predictive of lymph node metastasis in depressed early gastric cancer. Am J Surg, 2002, 183(2): 168-172 PMID: 11918883

[9] BickenbachK, StrongVE. Comparisons of Gastric Cancer Treatments: East vs. West. J Gastric Cancer, 2012, 12(2): 55-62 PMID: 22792517

[10] Japanese Classification of Gastric Carcinoma 2nd English Edition. Gastric Cancer, 1998,1(1):10–24

[11] BonenkampJJ, HermansJ, SasakoM, et al. . Extended Lymph-Node Dissection for Gastric Cancer. N Engl J Med, 1999, 340(12): 908-914 PMID: 10089184

[12] LiC, KimS, LaiJF, et al. . Solitary lymph node metastasis in gastric cancer. J Gastrointest Surg, 2008, 12(3): 550-554 PMID: 17786527

[13] Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer, 2011,14(2):113–123

[14] GotodaT, YanagisawaA, SasakoM, et al. . Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer, 2000, 3(4): 219-225 PMID: 11984739

[15] KelderW, NimuraH, TakahashiN, et al. . Sentinel node mapping with indocyanine green (ICG) and infrared ray detection in early gastric cancer: An accurate method that enables a limited lymphadenectomy. EJSO, 2010, 36(6): 552-558 PMID: 20452171

[16] MaruyamaK G P, OkabayashiK, et al. . Lymph Node Metastases of Gastric Cancer: General Pattern in 1931 Patients. Ann Surg, 1989, 210(5): 596-602 PMID: 2818028 PMCID: 1357792

[17] Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer, 2011,14(2):101–112

[18] KosakaT, UeshigeN, SugayaJ, et al. . Lymphatic routes of the stomach demonstrated by gastric carcinomas with solitary lymph node metastasis. Surg Today, 1999, 29(8): 695-700 PMID: 10483741

[19] MortonDL, WenD, WongJH, et al. . Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg, 1992, 127(4): 392-399 PMID: 1558490

[20] VeronesiU, PaganelliG, VialeG, et al. . A Randomized Comparison of Sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer. N Engl J Med, 2003, 349(6): 546-553 PMID: 12904519

[21] AlbertiniJJ, LymanGH, CoxC, et al. . Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA, 1996, 276(22): 1818-1822 PMID: 8946902

[22] KitagawaY, FujiiH, MukaiM, et al. . The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am, 2000, 80(6): 1799-1809 PMID: 11140874

[23] TakeuchiH, KitagawaY. Sentinel Node Navigation Surgery in Patients with Early Gastric Cancer. Dig Surg, 2013, 30(2): 104-111 PMID: 23867586

[24] KinamiS, FujimuraT, OjimaE, et al. . PTD classification: proposal for a new classification of gastric cancer location based on physiological lymphatic flow. Int J Clin Oncol, 2008, 13(4): 320-329 PMID: 18704632

[25] KitagawaY, TakeuchiH, TakagiY, et al. . Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol, 2013, 31(29): 3704-3710 PMID: 24019550

[26] KitagawaY, KitanoS, KubotaT, et al. . Minimally invasive surgery for gastric cancer — toward a confluence of two major streams: a review. Gastric Cancer, 2005, 8(2): 103-110 PMID: 15864717

[27] HiratsukaM, MiyashiroI, IshikawaO, et al. . Application of sentinel node biopsy to gastric cancer surgery. Surgery, 2001, 129(3): 335-340 PMID: 11231462

[28] ParkDJ, LeeHJ, LeeHS, et al. . Sentinel node biopsy for cT1 and cT2a gastric cancer. Eur J Surg Oncol, 2006, 32(1): 48-54 PMID: 16269225

[29] MiyashiroI. What is the problem in clinical application of sentinel node concept to gastric cancer surgery?. J Gastric Cancer, 2012, 12(1): 7-12 PMID: 22500258 PMCID: 3319803

[30] CanMF, YagciG, CetinerS. Sentinel lymph node biopsy for gastric cancer: Where do we stand?. World J Gastrointest Surg, 2011, 3(9): 131-137 PMID: 22007282 PMCID: 3192223

[31] OhdairaH, NimuraH, TakahashiN, et al. . The possibility of performing a limited resection and a lymphadenectomy for proximal gastric carcinoma based on sentinel node navigation. Surg Today, 2009, 39(12): 1026-1031 PMID: 19997796

[32] TakeuchiH, KitagawaY. New Sentinel Node Mapping Technologies for Early Gastric Cancer. Ann Surg Oncol, 2013, 20(2): 522-532 PMID: 22941161

[33] HayashiH, OchiaiT, MoriM, et al. . Sentinel lymph node mapping for gastric cancer using a dual procedure with dye-and gamma probe-guided techniques. J Am Coll Surg, 2003, 196(1): 68-74 PMID: 12517553

[34] LeeJH, RyuKW, NamBH, et al. . Factors associated with detection failure and false-negative sentinel node biopsy findings in gastric cancer: Results of prospective single center trials. J Surg Oncol, 2009, 99(3): 137-142 PMID: 19117015

[35] LeeJS, DouglassHO. D2 dissection for gastric cancer. Surg Oncol, 1997, 6(4): 215-225 PMID: 9775408